Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue and Ropivacaine for Post-Hemorrhoidectomy Analgesia
NCT07164807Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Putian University
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylene blue in hemorrhoid, sponsored by Affiliated Hospital of Putian University. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
methylene blue
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on NCT07164807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07164807.